Bile acids: a potential role in the pathogenesis of pharyngeal malignancy

Clinical Otolaryngology

Volumn 42, Issue 5, 2017, Pages 969-973

  Shellman, Z ^a   Aldhahrani, A ^a   Verdon, B ^a   Mather, M ^a   Paleri, V ^a,b   Wilson, J ^a,b   Pearson, J ^a   Ward, C ^a   Powell, J ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1; GASTROINTESTINAL AGENT;

ARTICLE; CANCER CELL; CANCER RISK; CELL VIABILITY ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; GASTROESOPHAGEAL REFLUX; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; PATHOGENESIS; PHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE TECHNIQUE; HYPOPHARYNX TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

BILE ACIDS AND SALTS; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; GASTROINTESTINAL AGENTS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MATRIX METALLOPROTEINASE 9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 85010213720     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/coa.12822     Document Type: Article

References (28)

1. Mehanna H., Paleri V., West C.M. et al. (2010) Head and neck cancer–Part 1: epidemiology, presentation, and prevention. BMJ 341, c4684
2. Mehanna H., West C.M., Nutting C. et al. (2010) Head and neck cancer–Part 2: treatment and prognostic factors. BMJ 341, c4690
3. Zhang D., Zhou J., Chen B. et al. (2014) Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis. Acta Otolaryngol. 134, 982–989
4. Sereg-Bahar M., Jerin A. & Hocevar-Boltezar I. (2015) Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer. Radiol. Oncol. 49, 59–64
5. Bredenoord A.J., Pandolfino J.E. & Smout A.J. (2013) Gastro-oesophageal reflux disease. Lancet 381, 1933–1942
6. Ford C.N. (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294, 1534–1540
7. Merati A.L., Lim H.J., Ulualp S.O. et al. (2005) Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann. Otol. Rhinol. Laryngol. 114, 177–182
8. Wang L., Liu X., Liu Y.L. et al. (2010) Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs. Otolaryngol. Head Neck Surg. 143, 765–771
9. Sereg-Bahar M., Jerin A., Jansa R. et al. (2015) Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux – a prospective comparative study. Clin. Otolaryngol. 40, 234–239
10. Johnston N., Dettmar P.W., Lively M.O. et al. (2006) Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann. Otol. Rhinol. Laryngol. 115, 47–58
11. Samuels T.L., Handler E., Syring M.L. et al. (2008) Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. Ann. Otol. Rhinol. Laryngol. 117, 688–695
12. Samuels T.L. & Johnston N. (2009) Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol. Head Neck Surg. 141, 559–563
13. Johnston N., Wells C.W., Samuels T.L. et al. (2010) Rationale for targeting pepsin in the treatment of reflux disease. Ann. Otol. Rhinol. Laryngol. 119, 547–558
14. Johnston N., Wells C.W., Samuels T.L. et al. (2009) Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann. Otol. Rhinol. Laryngol. 118, 677–685
15. Cronin J., Williams L., McAdam E. et al. (2010) The role of secondary bile acids in neoplastic development in the oesophagus. Biochem. Soc. Trans. 38, 337–342
16. Yen C.J., Izzo J.G., Lee D.F. et al. (2008) Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res. 68, 2632–2640
17. Ajouz H., Mukherji D. & Shamseddine A. (2014) Secondary bile acids: an underrecognized cause of colon cancer. World J. Surg. Oncol. 12, 164
18. Cheng K. & Raufman J.P. (2005) Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem. Pharmacol. 70, 1035–1047
19. Graves C.A., Abboodi F.F., Tomar S. et al. (2014) The translational significance of epithelial-mesenchymal transition in head and neck cancer. Clin. Transl. Med. 3, 60
20. Logullo A.F., Nonogaki S., Miguel R.E. et al. (2003) Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J. Oral Pathol. Med. 32, 139–145
21. Lamouille S., Xu J. & Derynck R. (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196
22. Sun L., Diamond M.E., Ottaviano A.J. et al. (2008) Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6, 10–20
23. Hofmann A.F. (1999) THe continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 159, 2647–2658
24. Parikh S., Brownlee I.A., Robertson A.G. et al. (2013) Are the enzymatic methods currently being used to measure bronchoalveolar lavage bile salt levels fit for purpose? J. Heart Lung Transplant. 32, 418–423
25. Shaheen N. & Ransohoff D.F. (2002) Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 287, 1972–1981
26. Galli J., Cammarota G., Calo L. et al. (2002) The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 112, 1861–1865
27. Sung M.W., Roh J.L., Park B.J. et al. (2003) Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 113, 1059–1063
28. Sasaki C.T., Issaeva N. & Vageli D.P. (2016) In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis. Head Neck 38(Suppl. 1), E1381–E1391